(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidSept 25 (Reuters) - Today we highligh
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidSept 23 (Reuters) - Today we report o
By Nancy LapidSept 18 (Reuters) - Today we feature an important genetic discovery that could help identify never-smokers at high risk of developing lung cancer. We also rep
Two late-stage trials found Opus Genetics' phentolamine eye drops improved night vision, glare and halo symptoms in patients with impaired low-light visual acuity. Separately, a survey of U.S. cancer centers found widespread shortages of key generic oncology drugs, including ifosfamide, carboplatin and Bacillus Calmette-Guérin.
At the European Respiratory Society Congress, AstraZeneca's tozorakimab reduced moderate-to-severe COPD exacerbations in two late-stage trials. Separate studies found high-dose influenza vaccination lowered hospitalization risk in older adults with chronic lung disease and identified brain-structure differences in patients with severe type-2 asthma.
Today we feature two early studies, one that points toward a possible way to prevent nerve damage from chemotherapy drugs and another that reveals previously unrecognized effects of bacteria that are known to make adults very sick but that were thought to be harmless to babies.
Researchers identified 36 genes linked to obsessive-compulsive and chronic tic disorders, revealing shared biological pathways and potential targets for novel therapeutics. Separately, blocking the mitochondrial protein EFHD1 reduced fatty liver injury and scarring in preclinical models, supporting a potential drug development strategy.
